Orbit Genomics® is transforming the diagnosis, treatment, and prevention of complex diseases — including cancer, heart disease, and neurological diseases — with our patented, AI-powered OrbiSeq™ platform. Our first product, OrbiSeq™-L, is the first and only blood test accurate enough to diagnose early-stage cancer, not just detect it. Cancer is the second leading cause of death, and Lung Cancer is the deadliest form of cancer, largely because it is diagnosed too late. Our simple blood test replaces invasive and expensive biopsies for diagnosing early-stage lung cancer, the world’s deadliest cancer. Orbit is changing that by making early, accurate diagnosis simple and accessible. Backed by two decades of research, future OrbiSeq products will enable earlier intervention and prevention in cancer, heart disease, and neurological diseases.